STOCK TITAN

Genvor (GNVR) sets Series C preferred stock terms and issues first share

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Genvor Incorporated created a new Series C Preferred Stock class and issued one share under an existing advisory agreement. On May 5, 2026, the company filed a certificate of designation in Nevada setting aside four shares as Series C Preferred Stock with a par value of $0.001 per share.

These shares carry standard voting and dividend rights but preferential conversion rights into common stock. Each Series C share may convert, at the holder’s option, into common stock based on a $300,000 value divided by a specified market price formula that depends on whether Genvor is listed on a national exchange by April 14, 2027. On May 8, 2026, one Series C share was issued to Brio Advisory Group LLC as consideration under an advisory agreement, relying on a private offering exemption from registration.

Positive

  • None.

Negative

  • None.
Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Series C shares designated 4 shares Preferred stock designated as Series C on May 5, 2026
Liquidation preference $0.001 per share Nominal preference equal to par value for Series C
Conversion base amount $300,000 Numerator used to calculate Series C conversion into common stock
Listing deadline April 14, 2027 Date determining which conversion formula applies
Conversion price floor $1.00 per share Minimum price used when not listed on a national exchange
Series C share issued 1 share Issued to Brio Advisory Group LLC on May 8, 2026
Series C Preferred Stock financial
"designating the rights and preferences of Genvor’s Series C Preferred Stock"
A Series C preferred stock is a specific class of ownership issued during a later funding round that gives holders priority over common shareholders for getting paid and receiving dividends, like having a reserved lane in traffic when money is distributed. It often includes agreed rights such as a fixed payout, protection against dilution, and the option to convert into common shares, so investors treat it as a mix of safety and upside potential.
certificate of designation regulatory
"filed with the State of Nevada a certificate of designation"
A certificate of designation is a formal document that spells out the specific rights and rules attached to a particular class or series of stock, usually preferred shares. Think of it as a rulebook or menu that lists dividend terms, liquidation priority, conversion or redemption rights and any special voting protections; investors use it to judge how much income, control or downside protection those shares will provide compared with other securities.
liquidation preference financial
"Each share of Series C Preferred Stock will have a nominal liquidation preference"
A liquidation preference is a rule that determines who gets paid first and how much they receive when a company is sold, goes bankrupt, or distributes its assets. It gives certain investors a priority claim—often returning their original investment plus any agreed multiple—before other owners receive money, which shapes how much common shareholders and founders ultimately get; think of it as a front-of-the-line pass that affects payout order and investor returns.
conversion rights financial
"will not have preferential voting or dividend rights ... but will have preferential conversion rights"
Conversion rights are a contract feature that lets the holder change one kind of security—often a bond or preferred share—into another, typically common stock, at a predetermined rate. Investors care because conversion can provide upside if the stock rises (like swapping a ticket for a better prize), but it can also dilute existing shareholders and change ownership and voting power, affecting share value and strategy.
Section 4(a)(2) of the Securities Act of 1933 regulatory
"issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933"
Advisory Agreement financial
"entered into an Advisory Agreement (the “Advisory Agreement”) with Brio Advisory Group LLC"
false --09-30 0001792941 0001792941 2026-05-05 2026-05-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report:  May 5, 2026

 

GENVOR INCORPORATED

 (Exact name of Registrant as specified in its Charter)

 

Nevada 000-56589 83-2054746
(State or Other Jurisdiction of (Commission File Number) (I.R.S. Employer Identification No.)
Incorporation)    

 

1550 W Horizon Ridge Pkwy, Ste R #3040

Henderson, NV 89012

(Address of Principal Executive Offices)

 

(715) 903-6473

(Registrant’s Telephone Number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see general instruction A.2. below):

 

 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 Soliciting material pursuant to Rule 14-a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Title of each class   Trading Symbols(s)   Name of each exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 

 

 

Item 5.03Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

On May 5, 2026, Genvor Incorporated (“Genvor”) filed with the State of Nevada a certificate of designation (the “Designation”) designating the rights and preferences of Genvor’s Series C Preferred Stock (the “Series C Preferred Stock”).

 

Pursuant to the Designation, four (4) shares of preferred stock were designated as Series C Preferred Stock. Each share of Series C Preferred Stock will have a nominal liquidation preference equal to par value ($0.001 per share), will not have preferential voting or dividend rights (with each holder of a share of Series C Preferred Stock having one vote per share, and the right to participate equally with common stockholders), but will have preferential conversion rights. Each share of Series C Preferred Stock will convert at the option of the holder into a number of shares of common stock calculated as follows: (i) if Genvor’s common stock has been listed for trading on the Nasdaq Capital Market, the NYSE American, or another equivalent national securities exchange by April 14, 2027, $300,000 divided by the official closing price of the common stock reported on either https://www.nasdaq.com/market-activity/quotes/historical-nocp (if the common Stock has been listed on the Nasdaq Capital Market) or otcmarkets.com (if the common stock has not been listed on the Nasdaq Capital Market); or (ii) if Genvor’s common stock has not been listed for trading on the Nasdaq Capital Market, the NYSE American, or another equivalent national securities exchange by April 14, 2027, $300,000 divided by the greater of (x) the 5-day average closing price at the time of such conversion (as such closing prices are reported on otcmarkets.com), or (y) $1.00 per share.

 

The foregoing description of the Designation and the rights and preferences of the Series C Preferred Stock is qualified in its entirety by the full text of the Designation, which is filed as Exhibit 3.1 to, and incorporated by reference in, this report.

 

Item 3.02Unregistered Sales of Equity Securities.

 

As disclosed in the Current Report on Form 8-K filed by Genvor on April 22, 2026, on April 16, 2026, Genvor entered into an Advisory Agreement (the “Advisory Agreement”) with Brio Advisory Group LLC (“Brio”). On May 8, 2026, Genvor issued one (1) share of Series C Preferred Stock to Brio as required by the Advisory Agreement. That share was issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, as there was no general solicitation, and the issuance did not involve a public offering.

 

  Item 9.01 Financial Statements and Exhibits. 
     

(d) Exhibits

 

Exhibit No.   Description
     
3.1*   Certificate of Designation filed May 5, 2026
104   Cover Page Interactive Data File (embedded within the Inline XBRL Document)

 

* Filed herewith.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: May 11, 2026

 

  GENVOR INCORPORATED
   
 

By:  /s/ Chad Pawlak                            

Name: Chad Pawlak

Title:   Chief Executive Officer

 

 

 

 

 

 

 

 

FAQ

What did Genvor (GNVR) announce regarding its Series C Preferred Stock?

Genvor created a new Series C Preferred Stock class by filing a certificate of designation in Nevada, authorizing four shares with preferential conversion rights into common stock while retaining nominal liquidation value and standard voting and dividend participation.

How many Series C Preferred shares did Genvor (GNVR) designate and issue?

Genvor designated four Series C Preferred shares in total and issued one share to Brio Advisory Group LLC on May 8, 2026, as required by an advisory agreement previously disclosed, using a private placement exemption from Securities Act registration.

How are Genvor (GNVR) Series C Preferred shares converted into common stock?

Each Series C share can convert, at the holder’s option, into common stock based on $300,000 divided by a market price formula tied to Genvor’s trading status and either the official closing price or a 5‑day average closing price from specified sources.

What voting and dividend rights do Genvor (GNVR) Series C Preferred shares have?

Series C Preferred shares have one vote per share and the right to participate equally with common stockholders in dividends, without preferential voting or dividend rights, while retaining a nominal liquidation preference equal to the $0.001 par value per share.

Who received the first Genvor (GNVR) Series C Preferred share and why?

Brio Advisory Group LLC received one Series C Preferred share on May 8, 2026, as consideration under an advisory agreement dated April 16, 2026, with the issuance made as a non‑public offering under Section 4(a)(2) of the Securities Act of 1933.

What happens if Genvor (GNVR) is not listed on a national exchange by April 14, 2027?

If Genvor is not listed on Nasdaq, NYSE American, or another national exchange by April 14, 2027, each Series C share converts using $300,000 divided by the greater of the 5‑day average OTC closing price or $1.00 per share, affecting the resulting common share count.

Filing Exhibits & Attachments

4 documents